GLP-1 (Glucagon-like peptide-1)
 
Why in News?
On May 1, 2026, global health agencies extended "critical shortage" alerts for Zepbound and Wegovy, as manufacturers struggle to meet the overwhelming demand for weight-loss versions of these drugs.
 

What are GLP-1 Drugs?
  • The Hormone: They mimic the GLP-1 hormone naturally produced in the gut after eating.
  • The Mechanism:
    • Insulin Boost: Tells the pancreas to release more insulin (lowering blood sugar).
    • Appetite Suppression: Signals the brain that the stomach is "full."
    • Delayed Digestion: Slows down how fast the stomach empties, making people feel full for longer.
Popular Brands & Uses
  • Diabetes Treatment:
    • Ozempic (Semaglutide - injectable)
    • Mounjaro (Tirzepatide - dual-action GLP-1/GIP)
    • Rybelsus (Semaglutide - oral pill form)
  • Weight Management:
    • Wegovy (High-dose Semaglutide)
    • Zepbound (Tirzepatide specifically for obesity)
Major Benefits
  • Weight Loss: Patients typically lose 15% to 22% of their body weight over a year.
  • Heart Health: Clinical trials (SELECT trial) showed a 20% reduction in the risk of heart attacks and strokes.
  • Kidney Protection: Proven to slow the progression of chronic kidney disease in diabetic patients.
Side Effects & Risks
  • Gastrointestinal: Most common are nausea, vomiting, and constipation.
  • Muscle Loss: Rapid weight loss can lead to significant loss of lean muscle mass if not paired with protein intake and exercise.
  • "Ozempic Face": A term for the facial sagging that occurs after rapid subcutaneous fat loss.
  • Rare Risks: Potential for pancreatitis, gallbladder issues, and long-term concerns regarding "stomach paralysis" (gastroparesis).
Future Outlook
  • Oral Pills: Manufacturers are rushing to develop high-dose oral versions to eliminate the need for weekly injections.
  • Medicare Coverage: Intense lobbying is underway in the US to have these drugs covered for obesity, which could reshape national healthcare budgets.
  • Neurological Studies: Research is expanding into whether these drugs can slow Parkinson's or Alzheimer's by reducing brain inflammation.

Download Pdf
Get in Touch
logo Get in Touch